Engineered Veterinary Vectored Immunotherapy and Vaccines: EVVIVAX
EVVIVAX stems from new, European platform technologies, aims to offer novel therapeutic avenues to pet cancer patients, with the strong translational potential to complement current human Immune-Oncology approaches in the next future.
